Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 2
2011 1
2012 1
2013 5
2014 3
2015 7
2016 7
2017 11
2018 9
2019 8
2020 15
2021 16
2022 14
2023 14
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for breast cancer in women: an update review.
Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, El Kadmiri N. Fakhri N, et al. Among authors: dehbi h. Med Oncol. 2022 Sep 7;39(12):197. doi: 10.1007/s12032-022-01804-x. Med Oncol. 2022. PMID: 36071255 Review.
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators. Al-Lamee R, et al. Among authors: dehbi hm. Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Lancet. 2018. PMID: 29103656 Free article. Clinical Trial.
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG, Arram L, Ahmed N, Balogun M, Bennett K, Bordea E, Campos MG, Caverly E, Chau M, Cohen H, Dehbi HM, Doré CJ, Engelter ST, Fenner R, Freemantle N, Hunter R, James M, Lip GY, Murray ML, Norrving B, Sprigg N, Veltkamp R, Zaczyk I, Werring DJ; OPTIMAS investigators. Best JG, et al. Among authors: dehbi hm. Int J Stroke. 2022 Jun;17(5):583-589. doi: 10.1177/17474930211057722. Epub 2022 Jan 12. Int J Stroke. 2022. PMID: 35018878
MicroRNAs: Key Regulators in Lung Cancer.
El Founini Y, Chaoui I, Dehbi H, El Mzibri M, Abounader R, Guessous F. El Founini Y, et al. Among authors: dehbi h. Microrna. 2021;10(2):109-122. doi: 10.2174/2211536610666210527102522. Microrna. 2021. PMID: 34047262 Review.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S. Seddon B, et al. Among authors: dehbi hm. Lancet Oncol. 2017 Oct;18(10):1397-1410. doi: 10.1016/S1470-2045(17)30622-8. Epub 2017 Sep 4. Lancet Oncol. 2017. PMID: 28882536 Free PMC article. Clinical Trial.
Early phase dose-finding trials in virology.
Dehbi HM, Lowe DM, O'Quigley J. Dehbi HM, et al. Stat Med. 2021 Jan 30;40(2):240-253. doi: 10.1002/sim.8771. Epub 2020 Oct 14. Stat Med. 2021. PMID: 33053601
100 results